About
Mycophenolate mofetil is a potent immunosuppressant medication primarily utilized to prevent organ rejection in individuals who have undergone allogeneic transplantation of organs such as the kidney, heart, or liver. Its mechanism of action involves the selective, non-competitive, and reversible inhibition of inosine monophosphate dehydrogenase (IMPDH), a key enzyme in the de novo pathway of guanosine nucleotide synthesis. Lymphocytes, particularly T and B cells, are highly dependent on this pathway for their proliferation and function, whereas other cell types can utilize salvage pathways. By inhibiting IMPDH, mycophenolate effectively depletes guanosine nucleotides in lymphocytes, thereby suppressing their proliferation and differentiation, and ultimately attenuating the immune system's response against the transplanted organ. This targeted immunosuppression helps to reduce the incidence of acute rejection episodes and improve long-term graft survival. It is commonly administered as part of a multi-drug immunosuppressive regimen, often in conjunction with corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus, to achieve optimal immune modulation and minimize side effects.
Uses
- Prevention of kidney transplant rejection.
- Prevention of heart transplant rejection.
- Prevention of liver transplant rejection.
- Treatment of certain autoimmune diseases (off-label).
Directions For Use
Take exactly as prescribed by your doctor, usually twice daily, on an empty stomach. Do not crush, chew, or break the tablets.
Benefits
- Significantly reduces the risk of organ rejection.
- Effective in combination with other immunosuppressants.
- Improves long-term graft survival rates.
- Helps maintain immune system balance post-transplant.
- Available in various strengths for tailored dosing.
- Supports overall patient well-being after transplantation.
Side Effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Leukopenia (low white blood cell count)
- Anemia (low red blood cell count)
- Thrombocytopenia (low platelet count)
- Increased risk of infections
- Increased risk of certain cancers (lymphoma, skin cancer)
- Headache
- Hypertension
- Insomnia
Safety Measures
- Alcohol - Avoid or limit alcohol consumption as it may increase the risk of gastrointestinal side effects and liver toxicity.
- Pregnancy - Highly teratogenic; contraindicated in pregnancy due to severe birth defects. Effective contraception is mandatory.
- Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and harm the infant.
- Liver - Use with caution in patients with severe liver impairment; dose adjustments may be necessary.
- Kidney - Dose adjustments may be required in patients with severe renal impairment.
- Lung - Rarely associated with interstitial lung disease; monitor for new or worsening respiratory symptoms.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!